Showing 8,961 - 8,980 results of 18,392 for search 'significant ((((((a decrease) OR (we decrease))) OR (nn decrease))) OR (mean decrease))', query time: 0.74s Refine Results
  1. 8961

    Table_1_Validation of the CRAVE-C scale in Chinese adults: a four-study examination of competing motivations for physical activity versus rest.docx by Zhihui Cheng (296359)

    Published 2024
    “…In Study 4, the athlete group demonstrated a significant increase in “Move” desire from baseline to post-training, whereas the non-athlete group reported a significant decrease in “Move” desire from baseline to post-training.…”
  2. 8962

    Data Sheet 1_Adjunctive esketamine in propofol-based sedation for gastrointestinal endoscopy: a systematic review and meta-analysis of randomized trials.docx by Jiazheng Qi (22679312)

    Published 2025
    “…Esketamine added to propofol decreased involuntary movement (RR: 0.61, 95% CI: 0.42 to 0.92; P = 0.02; I<sup>2</sup> = 77.2%; low quality) and reduced the propofol consumption (mean difference [MD]: −0.94, 95% CI: −1.53 to −0.35 mg/kg; P < 0.01; I<sup>2</sup> = 96.2%; low quality). …”
  3. 8963

    Data Sheet 1_The efficacy and safety of danuglipron and orforglipron in patients with type 2 diabetes and obesity: a systematic review and meta-analysis.docx by Jingjing Zhou (179820)

    Published 2025
    “…Meta-analysis results demonstrated that danuglipron significantly decreased HbA1c (mean difference [MD]: −0.90; 95% CI: −1.06, −0.74), FPG (MD: −24.66; 95% CI: −30.45, −18.86) and weight (MD: −2.17; 95% CI: −3.10, −1.23) and improved FPI (MD: 2.94; 95% CI: 1.50, 4.38). …”
  4. 8964

    Table 1_Carnosine as a protective metabolic mediator in inflammatory lung injury by inhibiting macrophage infiltration and M1-like polarization.docx by Lianjie Ruan (22660265)

    Published 2025
    “…Multiplex immunofluorescence further demonstrated a significant reduction of macrophage accumulation in the peribronchial regions of the lung following carnosine administration. …”
  5. 8965

    Table 2_Carnosine as a protective metabolic mediator in inflammatory lung injury by inhibiting macrophage infiltration and M1-like polarization.xlsx by Lianjie Ruan (22660265)

    Published 2025
    “…Multiplex immunofluorescence further demonstrated a significant reduction of macrophage accumulation in the peribronchial regions of the lung following carnosine administration. …”
  6. 8966

    A well-resolved phylogeny of <i>Epilobium</i> (Onagraceae) taxa in the British Isles finds no correlation between genomic divergence and the outcome of hybridisation by Kaitlin Saward (22126620)

    Published 2025
    “…All were likely to be F<sub>1</sub> hybrids.</p> <p>We did not detect a significant relationship between parental divergence and hybridisation likelihood and/or hybrid fertility in <i>Epilobium</i> sect. …”
  7. 8967

    Image 2_Evaluating dexmedetomidine in mitigating emergence agitation and perioperative complications in pediatric tonsillectomy and/or adenoidectomy: a systematic review and meta-a... by Jihong He (3527105)

    Published 2025
    “…Subgroup analysis of delivery methods, timing, and dosage (Dex ≥0.5 μg/kg) indicated that Dex significantly decreased the incidence of EA (P < 0.05). …”
  8. 8968

    Image 1_Evaluating dexmedetomidine in mitigating emergence agitation and perioperative complications in pediatric tonsillectomy and/or adenoidectomy: a systematic review and meta-a... by Jihong He (3527105)

    Published 2025
    “…Subgroup analysis of delivery methods, timing, and dosage (Dex ≥0.5 μg/kg) indicated that Dex significantly decreased the incidence of EA (P < 0.05). …”
  9. 8969

    Functional iKIR do not consistently modify detrimental genotypes. by Laura Mora-Bitria (20477525)

    Published 2024
    “…In the corresponding permutation test the p-value becomes even less significant (P <b>=</b> 0.19). We conclude that there is no evidence that detrimental class II drivers are modified by functional iKIR.…”
  10. 8970

    Image_3_RETRACTED: Ammonia Scavenger Restores Liver and Muscle Injury in a Mouse Model of Non-alcoholic Steatohepatitis With Sarcopenic Obesity.TIF by Zi-Xuan Wang (134651)

    Published 2025
    “…Hepatic infiltration of inflammatory cells and collagen deposition area were significantly decreased in HFD group by LOLA treatment. …”
  11. 8971

    Image_4_RETRACTED: Ammonia Scavenger Restores Liver and Muscle Injury in a Mouse Model of Non-alcoholic Steatohepatitis With Sarcopenic Obesity.TIF by Zi-Xuan Wang (134651)

    Published 2025
    “…Hepatic infiltration of inflammatory cells and collagen deposition area were significantly decreased in HFD group by LOLA treatment. …”
  12. 8972

    Image_1_RETRACTED: Ammonia Scavenger Restores Liver and Muscle Injury in a Mouse Model of Non-alcoholic Steatohepatitis With Sarcopenic Obesity.TIF by Zi-Xuan Wang (134651)

    Published 2025
    “…Hepatic infiltration of inflammatory cells and collagen deposition area were significantly decreased in HFD group by LOLA treatment. …”
  13. 8973

    Image_2_RETRACTED: Ammonia Scavenger Restores Liver and Muscle Injury in a Mouse Model of Non-alcoholic Steatohepatitis With Sarcopenic Obesity.TIF by Zi-Xuan Wang (134651)

    Published 2025
    “…Hepatic infiltration of inflammatory cells and collagen deposition area were significantly decreased in HFD group by LOLA treatment. …”
  14. 8974

    DataSheet1_Risk of bone fracture by using dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors in patients wit... by Mohamed E. A. Mostafa (19834779)

    Published 2024
    “…The risk of fracture was identified with the follow-up duration for each class. We found a significant decrease in the fracture risk by about 87% associated with patients who used SGLT2 inhibitors in combination with other glucose-lowering medications, followed by SGLT2 inhibitors alone by about 67%, then GLP-1 receptor agonists by about 60%, and at last DPP-4 inhibitors by about 55%.…”
  15. 8975

    DataSheet2_Risk of bone fracture by using dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors in patients wit... by Mohamed E. A. Mostafa (19834779)

    Published 2024
    “…The risk of fracture was identified with the follow-up duration for each class. We found a significant decrease in the fracture risk by about 87% associated with patients who used SGLT2 inhibitors in combination with other glucose-lowering medications, followed by SGLT2 inhibitors alone by about 67%, then GLP-1 receptor agonists by about 60%, and at last DPP-4 inhibitors by about 55%.…”
  16. 8976

    DataSheet3_Risk of bone fracture by using dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors in patients wit... by Mohamed E. A. Mostafa (19834779)

    Published 2024
    “…The risk of fracture was identified with the follow-up duration for each class. We found a significant decrease in the fracture risk by about 87% associated with patients who used SGLT2 inhibitors in combination with other glucose-lowering medications, followed by SGLT2 inhibitors alone by about 67%, then GLP-1 receptor agonists by about 60%, and at last DPP-4 inhibitors by about 55%.…”
  17. 8977

    Enrollment and randomization. by Helene Høgsdal (21161981)

    Published 2025
    “…No significant findings were found in the intention-to-treat analyses, but the results from per-protocol analyses showed a decrease in hyperactivity problems among the adolescents that had used the app (<i>F</i>(4,1585) = 2.89, <i>p</i> =.021). …”
  18. 8978

    Descriptive Statistics at Baseline. by Helene Høgsdal (21161981)

    Published 2025
    “…No significant findings were found in the intention-to-treat analyses, but the results from per-protocol analyses showed a decrease in hyperactivity problems among the adolescents that had used the app (<i>F</i>(4,1585) = 2.89, <i>p</i> =.021). …”
  19. 8979

    Scores vs Skip ratios on single-agent task. by Hongjie Zhang (136127)

    Published 2025
    “…Firstly, we incorporate a state skipping branch into the actor network to bypass states with minimal impact. …”
  20. 8980

    Time(s) and GFLOPs savings of single-agent tasks. by Hongjie Zhang (136127)

    Published 2025
    “…Firstly, we incorporate a state skipping branch into the actor network to bypass states with minimal impact. …”